Literature DB >> 21402993

Assessing susceptibility to age-related macular degeneration with genetic markers and environmental factors.

Yuhong Chen1, Jiexi Zeng, Chao Zhao, Kevin Wang, Elizabeth Trood, Jeanette Buehler, Matthew Weed, Daniel Kasuga, Paul S Bernstein, Guy Hughes, Victoria Fu, Jessica Chin, Clara Lee, Maureen Crocker, Matthew Bedell, Francesca Salasar, Zhenglin Yang, Michael Goldbaum, Henry Ferreyra, William R Freeman, Igor Kozak, Kang Zhang.   

Abstract

OBJECTIVES: To evaluate the independent and joint effects of genetic factors and environmental variables on advanced forms of age-related macular degeneration (AMD), including geographic atrophy and choroidal neovascularization, and to develop a predictive model with genetic and environmental factors included.
METHODS: Demographic information, including age at onset, smoking status, and body mass index, was collected for 1844 participants. Genotypes were evaluated for 8 variants in 5 genes related to AMD. Unconditional logistic regression analyses were performed to generate a risk predictive model.
RESULTS: All genetic variants showed a strong association with AMD. Multivariate odds ratios were 3.52 (95% confidence interval, 2.08-5.94) for complement factor H, CFH rs1061170 CC, 4.21 (2.30-7.70) for CFH rs2274700 CC, 0.46 (0.27-0.80) for C2 rs9332739 CC/CG, 0.44 (0.30-0.66) for CFB rs641153 TT/CT, 10.99 (6.04-19.97) for HTRA1/LOC387715 rs10490924 TT, and 2.66 (1.43-4.96) for C3 rs2230199 GG. Smoking was independently associated with advanced AMD after controlling for age, sex, body mass index, and all genetic variants.
CONCLUSION: CFH confers more risk to the bilaterality of geographic atrophy, whereas HTRA1/LOC387715 contributes more to the bilaterality of choroidal neovascularization. C3 confers more risk for geographic atrophy than choroidal neovascularization. Risk models with combined genetic and environmental factors have notable discrimination power. CLINICAL RELEVANCE: Early detection and risk prediction of AMD could help to improve the prognosis of AMD and to reduce the outcome of blindness. Targeting high-risk individuals for surveillance and clinical interventions may help reduce disease burden.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21402993      PMCID: PMC4134685          DOI: 10.1001/archophthalmol.2011.10

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  33 in total

1.  Complement factor H polymorphism in age-related macular degeneration.

Authors:  Robert J Klein; Caroline Zeiss; Emily Y Chew; Jen-Yue Tsai; Richard S Sackler; Chad Haynes; Alice K Henning; John Paul SanGiovanni; Shrikant M Mane; Susan T Mayne; Michael B Bracken; Frederick L Ferris; Jurg Ott; Colin Barnstable; Josephine Hoh
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

2.  CFH, ELOVL4, PLEKHA1 and LOC387715 genes and susceptibility to age-related maculopathy: AREDS and CHS cohorts and meta-analyses.

Authors:  Yvette P Conley; Johanna Jakobsdottir; Tammy Mah; Daniel E Weeks; Ronald Klein; Lewis Kuller; Robert E Ferrell; Michael B Gorin
Journal:  Hum Mol Genet       Date:  2006-09-25       Impact factor: 6.150

3.  Test for interaction between two unlinked loci.

Authors:  Jinying Zhao; Li Jin; Momiao Xiong
Journal:  Am J Hum Genet       Date:  2006-09-21       Impact factor: 11.025

4.  Common variation in three genes, including a noncoding variant in CFH, strongly influences risk of age-related macular degeneration.

Authors:  Julian Maller; Sarah George; Shaun Purcell; Jes Fagerness; David Altshuler; Mark J Daly; Johanna M Seddon
Journal:  Nat Genet       Date:  2006-08-27       Impact factor: 38.330

5.  CFH haplotypes without the Y402H coding variant show strong association with susceptibility to age-related macular degeneration.

Authors:  Mingyao Li; Pelin Atmaca-Sonmez; Mohammad Othman; Kari E H Branham; Ritu Khanna; Michael S Wade; Yun Li; Liming Liang; Sepideh Zareparsi; Anand Swaroop; Gonçalo R Abecasis
Journal:  Nat Genet       Date:  2006-08-27       Impact factor: 38.330

6.  Cigarette smoking strongly modifies the association of LOC387715 and age-related macular degeneration.

Authors:  Silke Schmidt; Michael A Hauser; William K Scott; Eric A Postel; Anita Agarwal; Paul Gallins; Frank Wong; Yu Sarah Chen; Kylee Spencer; Nathalie Schnetz-Boutaud; Jonathan L Haines; Margaret A Pericak-Vance
Journal:  Am J Hum Genet       Date:  2006-03-20       Impact factor: 11.025

7.  Hypothetical LOC387715 is a second major susceptibility gene for age-related macular degeneration, contributing independently of complement factor H to disease risk.

Authors:  Andrea Rivera; Sheila A Fisher; Lars G Fritsche; Claudia N Keilhauer; Peter Lichtner; Thomas Meitinger; Bernhard H F Weber
Journal:  Hum Mol Genet       Date:  2005-09-20       Impact factor: 6.150

8.  Complement factor H polymorphism and age-related macular degeneration.

Authors:  Albert O Edwards; Robert Ritter; Kenneth J Abel; Alisa Manning; Carolien Panhuysen; Lindsay A Farrer
Journal:  Science       Date:  2005-03-10       Impact factor: 47.728

Review 9.  Systematic review and meta-analysis of the association between complement factor H Y402H polymorphisms and age-related macular degeneration.

Authors:  Ammarin Thakkinstian; Pearline Han; Mark McEvoy; Wayne Smith; Josephine Hoh; Kristinn Magnusson; Kang Zhang; John Attia
Journal:  Hum Mol Genet       Date:  2006-08-11       Impact factor: 6.150

10.  Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration.

Authors:  Bert Gold; Joanna E Merriam; Jana Zernant; Lisa S Hancox; Andrew J Taiber; Karen Gehrs; Kevin Cramer; Julia Neel; Julie Bergeron; Gaetano R Barile; R Theodore Smith; Gregory S Hageman; Michael Dean; Rando Allikmets
Journal:  Nat Genet       Date:  2006-03-05       Impact factor: 38.330

View more
  35 in total

1.  Prediction of age-related macular degeneration in the general population: the Three Continent AMD Consortium.

Authors:  Gabriëlle H S Buitendijk; Elena Rochtchina; Chelsea Myers; Cornelia M van Duijn; Kristine E Lee; Barbara E K Klein; Stacy M Meuer; Paulus T V M de Jong; Elizabeth G Holliday; Ava G Tan; André G Uitterlinden; Theru S Sivakumaran; John Attia; Albert Hofman; Paul Mitchell; Johannes R Vingerling; Sudha K Iyengar; A Cecile J W Janssens; Jie Jin Wang; Ronald Klein; Caroline C W Klaver
Journal:  Ophthalmology       Date:  2013-10-10       Impact factor: 12.079

2.  The NEIGHBOR consortium primary open-angle glaucoma genome-wide association study: rationale, study design, and clinical variables.

Authors:  Janey L Wiggs; Michael A Hauser; Wael Abdrabou; Robert Rand Allingham; Donald L Budenz; Elizabeth Delbono; David S Friedman; Jae H Kang; Douglas Gaasterland; Terry Gaasterland; Richard K Lee; Paul R Lichter; Stephanie Loomis; Yutao Liu; Cathy McCarty; Felipe A Medeiros; Sayoko E Moroi; Lana M Olson; Anthony Realini; Julia E Richards; Frank W Rozsa; Joel S Schuman; Kuldev Singh; Joshua D Stein; Douglas Vollrath; Robert N Weinreb; Gadi Wollstein; Brian L Yaspan; Sachiko Yoneyama; Don Zack; Kang Zhang; Margaret Pericak-Vance; Louis R Pasquale; Jonathan L Haines
Journal:  J Glaucoma       Date:  2013-09       Impact factor: 2.503

Review 3.  Risk factors and biomarkers of age-related macular degeneration.

Authors:  Nathan G Lambert; Hanan ElShelmani; Malkit K Singh; Fiona C Mansergh; Michael A Wride; Maximilian Padilla; David Keegan; Ruth E Hogg; Balamurali K Ambati
Journal:  Prog Retin Eye Res       Date:  2016-05-06       Impact factor: 21.198

Review 4.  Genetic predictors of response to photodynamictherapy.

Authors:  Francesco Parmeggiani; Donato Gemmati; Ciro Costagliola; Francesco Semeraro; Paolo Perri; Sergio D'Angelo; Mario R Romano; Katia De Nadai; Adolfo Sebastiani; Carlo Incorvaia
Journal:  Mol Diagn Ther       Date:  2011-08-01       Impact factor: 4.074

5.  Complement factor B polymorphism (rs641153) and susceptibility to age-related macular degeneration: evidence from published studies.

Authors:  Xin Wang; Ying Zhang; Mao-Nian Zhang
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

6.  Association of coding and UTR variants in the known regions with wet age-related macular degeneration in Han Chinese population.

Authors:  Lulin Huang; Xiongze Zhang; Pancy O S Tam; Haoyu Chen; Fang Hao; Chi-Pui Pang; Fen Wen; Zhenglin Yang
Journal:  J Hum Genet       Date:  2018-07-19       Impact factor: 3.172

7.  Systemic complement inhibition with eculizumab for geographic atrophy in age-related macular degeneration: the COMPLETE study.

Authors:  Zohar Yehoshua; Carlos Alexandre de Amorim Garcia Filho; Renata Portella Nunes; Giovanni Gregori; Fernando M Penha; Andrew A Moshfeghi; Kang Zhang; Srinivas Sadda; William Feuer; Philip J Rosenfeld
Journal:  Ophthalmology       Date:  2013-11-26       Impact factor: 12.079

8.  Harmonizing the classification of age-related macular degeneration in the three-continent AMD consortium.

Authors:  Ronald Klein; Stacy M Meuer; Chelsea E Myers; Gabriëlle H S Buitendijk; Elena Rochtchina; Farzana Choudhury; Paulus T V M de Jong; Roberta McKean-Cowdin; Sudha K Iyengar; Xiaoyi Gao; Kristine E Lee; Johannes R Vingerling; Paul Mitchell; Caroline C W Klaver; Jie Jin Wang; Barbara E K Klein
Journal:  Ophthalmic Epidemiol       Date:  2014-02       Impact factor: 1.648

9.  Inclusion of genotype with fundus phenotype improves accuracy of predicting choroidal neovascularization and geographic atrophy.

Authors:  Lorah T Perlee; Aruna T Bansal; Karen Gehrs; Jeffrey S Heier; Karl Csaky; Rando Allikmets; Paul Oeth; Toni Paladino; Daniel H Farkas; P Lyle Rawlings; Gregory S Hageman
Journal:  Ophthalmology       Date:  2013-03-21       Impact factor: 12.079

10.  Genetic studies of age-related macular degeneration: lessons, challenges, and opportunities for disease management.

Authors:  Rinki Ratna Priya; Emily Y Chew; Anand Swaroop
Journal:  Ophthalmology       Date:  2012-09-23       Impact factor: 12.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.